Funder
AstraZeneca United States
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, 2021. CA Cancer J Clin 71(1):7–33
2. Breast Cancer Facts [https://www.nationalbreastcancer.org/breast-cancer-facts]
3. Brouckaert O, Wildiers H, Floris G, Neven P (2012) Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health 4:511–520
4. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TA (2009) Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol 33(5):759–767
5. Figueroa-Magalhaes MC, Jelovac D, Connolly R, Wolff AC (2014) Treatment of HER2-positive breast cancer. Breast 23(2):128–136